Tilray Brands, Inc.
XETRA: 2HQ.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Irwin David Simon
- Employees
- 2,650
- Headquarters
- Leamington, Canada
- IPO year
- 2023
- Market cap
- €78.9M
- Website
- https://www.tilray.com
Loading 2HQ…
Loading profile data…Frequently asked questions about 2HQ
What does Tilray Brands, Inc. (2HQ.DE) do?
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
Where does 2HQ.DE trade?
Tilray Brands, Inc. (2HQ.DE) trades on the Deutsche Börse.
What sector is 2HQ.DE in?
Tilray Brands, Inc. (2HQ.DE) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tilray Brands, Inc.?
Irwin David Simon is the chief executive officer of Tilray Brands, Inc. (2HQ.DE).
Where is Tilray Brands, Inc. headquartered?
Tilray Brands, Inc. is headquartered in Canada.
Does 2HQ.DE pay a dividend?
Tilray Brands, Inc. (2HQ.DE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2HQ.DE go public?
Tilray Brands, Inc. (2HQ.DE) completed its initial public offering in 2023.